Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women

ClinicalTrials.gov ID: NCT00406640

Public ClinicalTrials.gov record NCT00406640. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 8:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, 8-Week Double-Blind Acute Phase Followed By a 6-Month Continuation Phase (Open-Label Or Double-Blind) Study to Evaluate the Efficacy, Safety, and Tolerability of DVS SR Versus Escitalopram in Postmenopausal Women With Major Depressive Disorder

Study identification

NCT ID
NCT00406640
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
595 participants

Conditions and interventions

Interventions

  • Desvenlafaxine succinate sustained-release (DVS SR) Drug
  • Escitalopram Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 70 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2006
Primary completion
Jan 31, 2008
Completion
Sep 30, 2008
Last update posted
Dec 27, 2023

2006 – 2008

United States locations

U.S. sites
52
U.S. states
26
U.S. cities
49
Facility City State ZIP Site status
Not listed Peoria Arizona 85381
Not listed Pasadena California 91107
Not listed San Diego California 92103
Not listed San Diego California 92108
Not listed Denver Colorado 80212
Not listed Cromwell Connecticut 06416
Not listed Farmington Connecticut 06030
Not listed Waterbury Connecticut 06708
Not listed Brooksville Florida 34613
Not listed Coral Springs Florida 33065
Not listed Fort Myers Florida 33912
Not listed Gainesville Florida 32607
Not listed Maitland Florida 32751
Not listed Atlanta Georgia 30328
Not listed Roswell Georgia 30076
Not listed Northfield Illinois 60093
Not listed Oak Brook Illinois 60523
Not listed Overland Park Kansas 66211
Not listed Wichita Kansas 67214
Not listed New Orleans Louisiana 70115
Not listed Shreveport Louisiana 71130
Not listed Baltimore Maryland 21208
Not listed Boston Massachusetts 02114
Not listed Fall River Massachusetts 02721
Not listed Saint Paul Minnesota 55101
Not listed Las Vegas Nevada 89106
Not listed Piscataway New Jersey 08854
Not listed Elmsford New York 10523
Not listed Hollis New York 11423
Not listed New York New York 10032
Not listed New York New York 10128
Not listed Syracuse New York 13210
Not listed Raleigh North Carolina 27612
Not listed Oklahoma City Oklahoma 73103
Not listed Philadelphia Pennsylvania 19104
Not listed Pittsburgh Pennsylvania 15206
Not listed Pittsburgh Pennsylvania 15213
Not listed East Providence Rhode Island 02914
Not listed Lincoln Rhode Island 02865
Not listed Charleston South Carolina 29407
Not listed Columbia South Carolina 29201
Not listed Mt. Pleasant South Carolina 29464
Not listed Memphis Tennessee 38117
Not listed Bellaire Texas 77401
Not listed Dallas Texas 75235
Not listed Denton Texas 76201
Not listed Houston Texas 77090
Not listed Burlington Vermont 05401
Not listed Charlottesville Virginia 22903
Not listed Richmond Virginia 23230
Not listed Morgantown West Virginia 26506
Not listed Middleton Wisconsin 53562

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00406640, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 27, 2023 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00406640 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →